Kyle Mikson
Stock Analyst at Canaccord Genuity
(0.79)
# 3,698
Out of 4,754 analysts
70
Total ratings
23.81%
Success rate
-20.61%
Average return
Main Sectors:
Stocks Rated by Kyle Mikson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NTRA Natera | Maintains: Buy | $180 | $143.11 | +25.78% | 7 | Feb 26, 2025 | |
| GH Guardant Health | Maintains: Buy | $42 → $60 | $40.74 | +47.28% | 5 | Feb 24, 2025 | |
| RGEN Repligen | Maintains: Hold | $165 → $170 | $155.38 | +9.41% | 2 | Feb 21, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $20 → $18 | $9.85 | +82.74% | 7 | Feb 13, 2025 | |
| ILMN Illumina | Maintains: Hold | $145 → $135 | $84.20 | +60.33% | 7 | Feb 7, 2025 | |
| XGN Exagen | Maintains: Buy | $5 → $7 | $3.05 | +129.89% | 2 | Jan 3, 2025 | |
| AKYA Akoya Biosciences | Maintains: Buy | $6 → $3.5 | $1.55 | +125.81% | 3 | Nov 15, 2024 | |
| LUCD Lucid Diagnostics | Maintains: Buy | $3 | $1.34 | +123.88% | 4 | Nov 14, 2024 | |
| QSI Quantum-Si incorporated | Maintains: Hold | $1.5 → $1 | $1.30 | -23.08% | 3 | Nov 13, 2024 | |
| EXAS Exact Sciences | Maintains: Buy | $95 → $75 | $47.55 | +57.73% | 9 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $42 | $21.27 | +97.46% | 3 | Oct 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3.5 → $3 | $1.32 | +128.14% | 7 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $25 | $7.09 | +252.61% | 4 | Apr 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3.5 | $0.71 | +390.88% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $3 → $2 | $0.62 | +223.62% | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $49 | $0.70 | +6,935.61% | 1 | Mar 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $19 | $2.36 | +705.08% | 1 | Jan 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $150 | $0.17 | +90,809.09% | 1 | Jan 29, 2021 |
Natera
Feb 26, 2025
Maintains: Buy
Price Target: $180
Current: $143.11
Upside: +25.78%
Guardant Health
Feb 24, 2025
Maintains: Buy
Price Target: $42 → $60
Current: $40.74
Upside: +47.28%
Repligen
Feb 21, 2025
Maintains: Hold
Price Target: $165 → $170
Current: $155.38
Upside: +9.41%
10x Genomics
Feb 13, 2025
Maintains: Buy
Price Target: $20 → $18
Current: $9.85
Upside: +82.74%
Illumina
Feb 7, 2025
Maintains: Hold
Price Target: $145 → $135
Current: $84.20
Upside: +60.33%
Exagen
Jan 3, 2025
Maintains: Buy
Price Target: $5 → $7
Current: $3.05
Upside: +129.89%
Akoya Biosciences
Nov 15, 2024
Maintains: Buy
Price Target: $6 → $3.5
Current: $1.55
Upside: +125.81%
Lucid Diagnostics
Nov 14, 2024
Maintains: Buy
Price Target: $3
Current: $1.34
Upside: +123.88%
Quantum-Si incorporated
Nov 13, 2024
Maintains: Hold
Price Target: $1.5 → $1
Current: $1.30
Upside: -23.08%
Exact Sciences
Nov 6, 2024
Maintains: Buy
Price Target: $95 → $75
Current: $47.55
Upside: +57.73%
Oct 29, 2024
Maintains: Buy
Price Target: $35 → $42
Current: $21.27
Upside: +97.46%
Aug 8, 2024
Maintains: Buy
Price Target: $3.5 → $3
Current: $1.32
Upside: +128.14%
Apr 29, 2024
Maintains: Buy
Price Target: $32 → $25
Current: $7.09
Upside: +252.61%
Mar 4, 2024
Reiterates: Buy
Price Target: $3.5
Current: $0.71
Upside: +390.88%
Aug 16, 2023
Maintains: Overweight
Price Target: $3 → $2
Current: $0.62
Upside: +223.62%
Mar 30, 2021
Initiates: Overweight
Price Target: $49
Current: $0.70
Upside: +6,935.61%
Jan 29, 2021
Initiates: Overweight
Price Target: $19
Current: $2.36
Upside: +705.08%
Jan 29, 2021
Initiates: Overweight
Price Target: $150
Current: $0.17
Upside: +90,809.09%